AI Model Predicts Kidney Cancer Therapy Response with High Accuracy

AI Model Developed for Predicting Kidney Cancer Treatment Response

Researchers at UT Southwestern Medical Center have made a significant breakthrough in the field of kidney cancer treatment. They have developed an artificial intelligence (AI)-based model that can accurately predict which patients with clear cell renal cell carcinoma (ccRCC) will benefit from anti-angiogenic therapy 1

1

2

The Challenge of Anti-Angiogenic Therapy

ccRCC is the most common subtype of kidney cancer, affecting nearly 435,000 people annually. When the disease metastasizes, anti-angiogenic therapies are often prescribed. These drugs work by inhibiting the formation of new blood vessels in tumors, thereby limiting their access to growth-fueling molecules 1

1

However, Dr. Payal Kapur, Professor of Pathology and Urology at UT Southwestern, explains that fewer than 50% of patients benefit from these drugs. This results in many patients being exposed to unnecessary toxicity and financial burden 2

2

AI Solution: Analyzing Histopathological Slides

To address this issue, the research team developed a predictive method using AI to assess histopathological slides - thinly cut tumor tissue sections stained to highlight cellular features. These slides are routinely part of a patient's standard diagnostic workup 1

1

Dr. Satwik Rajaram, Assistant Professor in the Lyda Hill Department of Bioinformatics, emphasizes the importance of this approach: "Our work demonstrates that histopathological slides, a readily available resource, can be mined to produce state-of-the-art biomarkers that provide insight on which treatments might benefit which patients" 2

2

The AI Model's Methodology

The researchers used deep learning to train their algorithm on two sets of data:

1. ccRCC histopathological slides matched with their corresponding Angioscore (a test assessing the expression of six blood vessel-associated genes)
2. Slides matched with a test they developed to assess blood vessels in tumor sections 1

   1

Unlike many deep learning algorithms, this approach is designed to be visually interpretable. It generates a visualization of the predicted blood vessels that correlates closely with the RNA-based Angioscore 2

2

Related Stories

AI analyzes tumor biopsies to predict immunotherapy success in rare cancers, quadrupling survival

AI-Powered Model Revolutionizes Bladder Cancer Treatment Predictions

AI Tool Achieves 91% Accuracy Assessing Lung Cancer Treatment Response Across Global Studies

AI Tool SCORPIO Predicts Cancer Immunotherapy Response Using Routine Blood Tests

Impressive Results

When evaluated using slides from over 200 patients not included in the training data, the AI model performed remarkably well:

• It predicted which patients were most likely to respond to anti-angiogenic therapies almost as accurately as the Angioscore
• The algorithm showed a responder will have a higher score than a non-responder 73% of the time, compared to 75% with Angioscore 1

  1

  2

  2

Future Implications

The study authors suggest that AI analysis of histopathological slides could eventually guide diagnostic, prognostic, and therapeutic decisions for various conditions. They plan to develop a similar algorithm to predict which ccRCC patients will respond to immunotherapy 1

1

This breakthrough could lead to more personalized and effective treatment strategies for kidney cancer patients, potentially reducing unnecessary treatments and improving overall patient outcomes.